Female hypogonadism: Evaluation of the hypothalamic-pituitary-ovarian axis

Pituitary

Volumn 11, Issue 2, 2008, Pages 163-169

  Rothman, Micol S ^a   Wierman, Margaret E ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Amenorrhea; Female hypogonadism; Hypopituitarism; Ovarian reserve testing

Indexed keywords

CLOMIFENE CITRATE; ESTRADIOL; ESTROGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR 54; GONADORELIN; GONADOTROPIN DERIVATIVE; HYDROCORTISONE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE; TESTOSTERONE; THYROID HORMONE; TRANSCRIPTION FACTOR HESX1; TRANSCRIPTION FACTOR LHX3;

AMENORRHEA; ANAMNESIS; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; GENE MUTATION; HEREDITY; HORMONE SUBSTITUTION; HUMAN; HYPERCORTISOLISM; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS DISEASE; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHYROIDISM; KARYOTYPING; LABORATORY TEST; MENSTRUATION DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHARMACOLOGICAL STIMULATION; PHYSICAL EXAMINATION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROLACTIN RELEASE; SENSITIVITY AND SPECIFICITY;

ADULT; AMENORRHEA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYPOGONADISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; OVARY; PITUITARY HORMONES; THYROID HORMONES;

EID: 43049170356     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-008-0109-3     Document Type: Article

References (31)

1. Welt CK, Hall JE (1997) Gonadotropin deficiency: Differential diagnosis and treatment. In: Wierman ME (ed) Diseases of the pituitary. Humana Press, Totowa, NJ, pp 221-246
2. Kodaman PH, Arici A (2007) Intra-uterine adhesions and fertility outcome: How to optimize success? Curr Opin Obstet Gynecol 19:207-214. Medline. doi: 10.1097/GCO.0b013e32814a6473
3. Goswami D, Conway GS (2007) Premature ovarian failure. Horm Res 68:196-202. Medline. doi: 10.1159/000102537
4. Sinha P, Kuruba N (2007) Premature ovarian failure. J Obstet Gynaecol 27:16-19. Medline. doi: 10.1080/01443610601016685
5. Ascoli P, Cavagnini F (2006) Hypopituitarism. Pituitary 9:335-342. Medline. doi: 10.1007/s11102-006-0416-5
6. Pickett CA, Gutierrez-Hartmann A (1997) Molecular and cellular ontogeny of distinct pituitary cell types. In: Wierman ME (ed) Diseases of the pituitary: Diagnosis and treatment. Humana Press, Totowa, NJ, pp 1-33
7. Dattani MT (2005) Growth hormone deficiency and combined pituitary hormone deficiency: Does the genotype matter? Clin Endocrinol (Oxf) 63:121-130. Medline. doi: 10.1111/j.1365-2265.2005.02289.x
8. Huhtaniemi I, Jiang M, Nilsson C, Pettersson K (1999) Mutations and polymorphisms in gonadotropin genes. Mol Cell Endocrinol 151:89-94. Medline. doi: 10.1016/S0303-7207(99)00015-5
9. Lofrano-Porto A, Barra GB, Giacomini LA et al (2007) Luteinizing hormone beta mutation and hypogonadism in men and women. N Engl J Med 357:897-904. Medline. doi: 10.1056/NEJMoa071999
10. Lillehei KO (1997) Neurosurgical approach to pituitary adenomas. In: Wierman ME (ed) Diseases of the pituitary: Diagnosis and treatment. Humana Press, Totowa, NJ, pp 361-376
11. Golkowski F, Trofimiuk M, Czepko R et al (2007) Two rare cases of pituitary metastases from breast and kidney cancers. Exp Clin Endocrinol Diabetes 115:537-540. Medline
12. McDermott M (1997) Infiltrative diseases of the pituitary gland. In: Wierman ME (ed) Diseases of the pituitary: Diagnosis and treatment. Humana Press, Totowa, NJ, pp 305-322
13. Moirand R, Adams PC, Bicheler V, Brissot P, Deugnier Y (1997) Clinical features of genetic hemochromatosis in women compared with men. Ann Intern Med 127:105-110. Medline
14. Rivera JA (2006) Lymphocytic hypophysitis: Disease spectrum and approach to diagnosis and therapy. Pituitary 9:35-45. Medline. doi: 10.1007/ s11102-006-6598-z
15. Rothman MS, Arciniegas DB, Filley CM, Wierman ME (2007) The neuroendocrine effects of traumatic brain injury. J Neuropsychiatry Clin Neurosci 19:363-372. Medline. doi: 10.1176/appi.neuropsych.19.4.363
16. Pitteloud N, Meysing A, Quinton R et al (2006) Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 254-255:60-69. Medline. doi: 10.1016/j.mce.2006.04.021
17. Pitteloud N, Zhang C, Pignatelli D et al (2007) From the cover: loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 104:17447-17452. Medline. doi: 10.1073/pnas.0707173104
18. Pitteloud N, Quinton R, Pearce S et al (2007) Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117:457-463. Medline. doi: 10.1172/JCI29884
19. Seminara SB, Messager S, Chatzidaki EE et al (2003) The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627. Medline. doi: 10.1056/ NEJMoa035322
20. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972-10976. Medline. doi: 10.1073/pnas.1834399100
21. Lee EJ, Jameson JL (1997) Gonadotropin (FSH and LH) pituitary tumors. In: Wierman ME (ed) Diseases of the pDtuitary: diagnosis and treatment. Humana Press, Totowa, NJ, pp 247-272
22. Genazzani AD, Ricchieri F, Lanzoni C, Strucchi C, Jasonni VM (2006) Diagnostic and therapeutic approach to hypothalamic amenorrhea. Ann N Y Acad Sci 1092:103-113. Medline. doi: 10.1196/annals.1365.009
23. Poppe K, Velkeniers B, Glinoer D (2007) Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 66:309-321. Medline. doi: 10.1111/ j.1365-2265.2007.02752.x
24. Bhagavath B, Layman LC (2007) The genetics of hypogonadotropic hypogonadism. Semin Reprod Med 25:272-286. Medline. doi: 10.1055/ s-2007-980221
25. van der Steeg JW, Steures P, Eijkemans MJ et al (2007) Predictive value and clinical impact of basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab 92:2163-2168. Medline. doi: 10.1210/jc.2006-2399
26. Navot D, Rosenwaks Z, Margalioth EJ (1987) Prognostic assessment of female fecundity. Lancet 330:645-647. Medline. doi: 10.1016/ S0140-6736(87)92439-1
27. Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, Te Velde ER (2004) Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: A comparison with basal markers for ovarian reserve. Hum Reprod 20:163-169. Medline. doi: 10.1093/humrep/deh553
28. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C (2007) Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve. Fertil Steril [Epub ahead of print]
29. New MI (2006) Extensive clinical experience: Nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 91:4205-4214. Medline. doi: 10.1210/ jc.2006-1645
30. Azziz R, Carmina E, Dewailly D et al (2006) Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245. Medline. doi: 10.1210/jc.2006-0178
31. Molitch ME, Russell EJ (1990) The pituitary "incidentaloma". Ann Intern Med 112:925-931. Medline